AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients

Acute kidney injury (AKI) is a frequent complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), but few studies have focused on AKI treated with kidney replacement therapy (AKI-KRT), particularly among critically ill patients. We investigated the incidence, risk factors, and 90-day mortality associated with AKI-KRT in 529 critically ill adult allo-HSCT recipients admitted to the ICU within 1-year post-transplant at two academic medical centers between 2011 and 2021. AKI-KRT occurred in 111 of the 529 patients (21.0%). Lower baseline eGFR, veno-occlusive disease, thrombotic microangiopathy, admission to an ICU within 90 days post-transplant, and receipt of invasive mechanical ventilation (IMV), total bilirubin >= 5.0 mg/dl, and arterial pH <7.40 on ICU admission were each associated with a higher risk of AKI-KRT. Of the 111 patients with AKI-KRT, 97 (87.4%) died within 90 days. Ninety-day mortality was 100% in each of the following subgroups: serum albumin <= 2.0 g/dl, total bilirubin >= 7.0 mg/dl, arterial pH <= 7.20, IMV with moderate-to-severe hypoxemia, and >= 3 vasopressors/inotropes at KRT initiation. AKI-KRT was associated with a 6.59-fold higher adjusted 90-day mortality in critically ill allo-HSCT vs. non-transplanted patients. Short-term mortality remains exceptionally high among critically ill allo-HSCT patients with AKI-KRT, highlighting the importance of multidisciplinary discussions prior to KRT initiation.

Automated summary

This study aimed to investigate the incidence, risk factors, and 90-day mortality associated with acute kidney injury treated with kidney replacement therapy (AKI-KRT) in critically ill adult patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). The study found that lower baseline eGFR, veno-occlusive disease, thrombotic microangiopathy, admission to ICU within 90 days post-transplant, invasive mechanical ventilation, total bilirubin >= 5.0 mg/dl, and arterial pH <7.40 on ICU admission were all associated with a higher risk of AKI-KRT. The short-term mortality rate was exceptionally high among AKI-KRT patients, highlighting the importance of multidisciplinary discussions before initiating kidney replacement therapy.